ASLAN Pharmaceuticals Ltd (ASLN)
0.4244
-0.02
(-5.08%)
USD |
NASDAQ |
May 06, 16:00
0.4114
-0.01
(-3.06%)
After-Hours: 20:00
ASLAN Pharmaceuticals Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | 12.00M |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 |
Date | Value |
---|---|
March 31, 2020 | 0.00 |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 1.290M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2020
12.00M
Maximum
Jun 2023
6.00M
Average
6.00M
Median
Accounts Receivable (Quarterly) Benchmarks
Dr Reddy's Laboratories Ltd | 939.36M |
Concord Medical Services Holdings Ltd | 10.37M |
WAVE Life Sciences Ltd | 21.09M |
Zai Lab Ltd | 59.20M |
CytoMed Therapeutics Ltd | -- |